United States · FDA National Drug Code directory
Members Mark Triple Antibiotic
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68196-400_218dba30-8aa5-4e64-81c5-8a0be537b348
- Product NDC
- 68196-400
- Form
- OINTMENT
- Composition / generic term
- bacitracin zinc, neomycin, polymyxin B
- Labeler
- Sam's West Inc
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20240905
- Source listing expiry
- 20261231
Source-listed ingredients
- BACITRACIN ZINC — 400 [USP'U]/g
- NEOMYCIN SULFATE — 3.5 mg/g
- POLYMYXIN B SULFATE — 5000 [USP'U]/g
These values do not establish equivalence or a dose recommendation.
Packages
- 3 TUBE in 1 CARTON (68196-400-21) / 28 g in 1 TUBE (68196-400-64) · 68196-400-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →